Multimodality Prediction of Success of Atrial Fibrillation Rhythm Control Strategy
NCT ID: NCT02009683
Last Updated: 2018-04-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
220 participants
OBSERVATIONAL
2014-05-31
2018-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Primary objectives To show that a model incorporating the novel predictors 17-lead ECG, Oesophageal-ECG and SNPs is superior to existing models in predicting maintenance of sinus rhythm after successful DCC in patients with persistent AF.
Secondary objectives To assess the predictive value of new predictors (the Oesophageal-ECG, 17-lead ECG and SNPs) for maintenance of SR after successful DCC separately.
To assess the predictive value of new predictors (the Oesophageal-ECG, 17-lead ECG and SNPs) for time to recurrence of AF.
To assess the predictive value of predictors with respect to complete failure of cardioversion.
To assess the predictive value of predictors with respect to cardiovascular morbidity.
Hypothesis The investigators hypothesise that a model incorporating the novel predictors the 17-leads ECG, Oesophageal-ECG and SNPs performs significantly better than existing models using only clinical, echocardiographic and ECG parameters on a standard 12-lead ECG in predicting maintenance of SR after successful DCC. In addition the investigators hypothesise that Oesophageal-ECG is the best single predictor for maintenance of SR after successful DCC.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Risk Profile for Patients With Atrial Fibrillation
NCT01510210
Risk Profile for Atrial Fibrillation
NCT01510197
Atrial Fibrillation Ablation Registry
NCT03075930
Reappraisal of Atrial Fibrillation: Interaction Between HyperCoagulability, Electrical Remodeling, and Vascular Destabilisation in the Progression of Atrial Fibrillation
NCT02726698
Risk Factors That Contribute to the Maintenance of Sinus Rhythm
NCT04655443
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Written informed consent.
* Patients \> 18 years old.
Exclusion Criteria
* Patients with known oesophageal disease.
* Patients with previous operations on throat or oesophagus.
* Postoperative atrial fibrillation.
* Patients with previous ablation for AF.
* Previous inclusion in this study.
* Patients on anti-arrhythmic drugs (AAD).
* Patients with pacemakers unable to detect AF and with a regular paced rhythm during AF.
* Planned ablation for AF.
* Myocardial infarction within the last 4 weeks.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maastricht University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
H Crijns, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Maastricht University Medical Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maastricht University Medical Centre
Maastricht, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Harry J Crijns, Md, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
METC 13-2-033.3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.